EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pain Severity Trajectories and Patient Profiles in Chronic Pain Patients Treated with Cannabis‐Based Medicinal Products: A k‐Means Clustering Analysis of the UK Medical Cannabis Registry

Simon Erridge iD, Aritra Datta iD, Aditya Mukherjee iD, Dhruv Vasooja iD, Ross Coomber, Sushil Beri, Shaheen A Khan, Mark W Weatherall, Michael W Platt, James J Rucker, Pedro A M Mediano, Mikael H Sodergren

The Journal of Clinical Pharmacology · 2026-10 · 66 (10)

DOI: 10.1002/jcph.70313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 16.10.2026. Verfasst von Simon Erridge und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Medical Marijuana, Chronic Pain. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis‐based medicinal products (CBMPs) are increasingly prescribed for chronic pain, yet the supporting evidence remains limited and the extent to which patients differ in their response is poorly understood. This study applied longitudinal k‐means clustering to pain‐severity trajectories in patients treated with CBMPs for chronic pain to distinguish patterns of response and identify the baseline characteristics predicting them over 24 months. A cohort study was undertaken of UK Medical Cannabis Registry participants whose primary indication was chronic pain. Pain, health‐related quality of life, anxiety, and sleep were assessed with patient‐reported outcome measures, including the Brief Pain Inventory Short Form (BPI‐SF), EuroQol 5‐Dimension 5‐Level (EQ‐5D‐5L), Generalised Anxiety Disorder‐7, and Single‐Item Sleep Quality Scale, at baseline up to 24 months. BPI‐SF pain‐severity trajectories were grouped by longitudinal k‐means clustering. The number of clusters was chosen using the gap statistic and predictors of cluster membership were examined by logistic regression. Of 3744 patients included, every outcome improved from baseline to 24 months, including BPI‐SF pain severity (d = 0.57), pain interference (d = 0.59), and the EQ‐5D‐5L index value (d = −0.76; all P < .001). More than half of patients achieved a minimal clinically important difference in each pain measure at 24 months. Five distinct trajectory clusters emerged. All ended below their baseline severity, but the magnitude and pattern of change varied markedly. Adverse events were reported by 14.37% (n = 538) of patients, predominantly mild or moderate. Baseline sleep quality, anxiety, and treatment indication were more strongly associated with response than product‐ or dose‐related factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical MarijuanaChronic PainHumansFemaleMaleRegistriesMiddle AgedUnited KingdomAdultCluster AnalysisQuality of LifePain MeasurementClustering AlgorithmsAgedAnxietySleepLongitudinal StudiesSeverity of Illness IndexCohort Studies

Stichwörter der Autor:innen

anxietycannabidiolcannabispainsleeptetrahydrocannabinol

Substanzen

Medical Marijuana

Autor:innen und Institutionen

  • Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Curaleaf Clinic, Curaleaf International, London, UK.
  • St. George's Hospital, London, UK.
  • Imperial College Healthcare NHS Trust, London, UK.
  • Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Buckinghamshire Healthcare NHS Trust, Amersham, UK.

ORCID-Profile: Simon Erridge, Aritra Datta, Aditya Mukherjee, Dhruv Vasooja

Zitieren

APA

Erridge, S., Datta, A., Mukherjee, A., Vasooja, D., Coomber, R., Beri, S., Khan, S. A., Weatherall, M. W., Platt, M. W., Rucker, J. J., Mediano, P. A. M., & Sodergren, M. H. (2026). Pain Severity Trajectories and Patient Profiles in Chronic Pain Patients Treated with Cannabis‐Based Medicinal Products: A k‐Means Clustering Analysis of the UK Medical Cannabis Registry. The Journal of Clinical Pharmacology, 66(10). https://doi.org/10.1002/jcph.70313

Vancouver

Erridge S, Datta A, Mukherjee A, Vasooja D, Coomber R, Beri S, et al. Pain Severity Trajectories and Patient Profiles in Chronic Pain Patients Treated with Cannabis‐Based Medicinal Products: A k‐Means Clustering Analysis of the UK Medical Cannabis Registry. The Journal of Clinical Pharmacology. 2026;66(10). doi:10.1002/jcph.70313

BibTeX
@article{Erridge2026,
  author = {Erridge, Simon and Datta, Aritra and Mukherjee, Aditya and Vasooja, Dhruv and Coomber, Ross and Beri, Sushil and Khan, Shaheen A and Weatherall, Mark W and Platt, Michael W and Rucker, James J and Mediano, Pedro A M and Sodergren, Mikael H},
  title = {Pain Severity Trajectories and Patient Profiles in Chronic Pain Patients Treated with Cannabis‐Based Medicinal Products: A k‐Means Clustering Analysis of the UK Medical Cannabis Registry},
  journal = {The Journal of Clinical Pharmacology},
  year = {2026},
  volume = {66},
  number = {10},
  doi = {10.1002/jcph.70313}
}
Kostenlos starten →